Skip to main content

Table 1 Correlation of PLEK2 expression with the clinicopathological features of GBC

From: PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway

  PLEK2(High) PLEK2 (Low) P value
N = 83 % N = 66 %  
Sexual      0.623
 Male 27 0.181 19 0.128  
 Female 56 0.376 47 0.315  
Age (years)      0.271
  ≤ 65 39 0.262 37 0.248  
  > 65 44 0.295 29 0.195  
Tumor size (cm)      0.256
  ≤ 3 35 0.235 34 0.228  
  > 3 48 0.322 32 0.215  
T      0.010*
 1–2 9 0.060 18 0.121  
 3–4 74 0.497 48 0.322  
N      0.195
 0 48 0.322 45 0.302  
 1–2 35 0.235 21 0.141  
M      0.841
 No 82 0.550 64 0.430  
 Yes 1 0.007 2 0.013  
TNM stage      0.010*
 I-II 9 0.060 18 0.121  
 III-IV 74 0.497 48 0.322  
Tumor location      0.336
 Body or bottom 73 0.490 62 0.416  
 Neck or duct 10 0.067 4 0.027  
Liver metastasis      0.014*
 No 44 0.295 48 0.322  
 Yes 39 0.262 18 0.121  
  1. *P < 0.05 was considered statistically significant
  2. χ2 test was performed